TABLE-Cmic <2309.T>-2008/09 parent results

Nov 6 (Reuters) -

CMIC CO LTD

PARENT-ONLY FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to

Sep 30, 2009 Sep 30, 2008 Sep 30, 2010

LATEST YEAR-AGO COMPANY

RESULTS RESULTS FORECASTS
Sales 14.30 13.05

(+9.6 pct) (+14.3 pct)
Operating 642 mln 1.25

(-48.7 pct) (+7.4 pct)
Recurring 585 mln 1.36

(-57.0 pct) (+16.8 pct)
Net 292 mln 735 mln

(-60.3 pct) (+37.7 pct)
EPS Y332.30 Y890.50
Annual div Y334.00 Y266.00 Y380.00
-Q2 div Y167.00 Y133.00 Y190.00
-Q4 div Y167.00 Y133.00 Y190.00

NOTE - Cmic Co Ltd conducts clinical trials on behalf of
pharmaceutical makers.

If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.

For latest earnings estimates made by Toyo Keizai, please
double click on 2309.TK1.